Carla Vozone is Vice President of Inhalation Strategy, Innovation and Partnerships at Catalent Pharma Solutions. Carla leads strategic growth initiatives for Catalent’s Inhalation business segment and oversees Product Development for Nasals and Inhaled Powders. She holds a PharmD and MSc in Pharmaceutical Technology from the Pharmacy School, University of Lisbon, a Master in Business Administration (MBA) with a specialization in Pharmaceutical Management from Rutgers Business School, New Jersey and a Certification in Business Development and Licensing from the University of Manchester. Carla is Immediate Past Chair of IPAC-RS, the leading industry consortium on regulatory science of orally inhaled and nasal drugs (OINDPs).